View

The Study

Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.

In simple terms

This study tried giving testosterone to men with liver disease and low testosterone and found they gained muscle and lost fat — but we can't be 100% sure it was the testosterone because we didn't see the full study. Still, since it was done like a fair test (some got the real stuff, some got fake), we can say it probably helped.

60%

Analysis score

60/ 90

Maximum 90 for a randomized controlled trial.

Where the score came from

Reporting0
Methodology60
Publication100
Statistical77
Study type (basis of the score)
Randomized Controlled Trial
Level 1b - Individual RCT
What’s the bottom line?

Men with serious liver disease and low testosterone got monthly testosterone shots or dummy shots for a year. Those who got testosterone built more muscle, lost fat, had stronger bones, more blood, and better blood sugar.

Where does this study sit?

Systematic Reviews & Meta-analyses

Max 100

Randomized Trials

Max 90

Cohort Studies

Max 72

Case-Control

Max 58

Cross-Sectional

Max 44

Case Reports & Series

Max 30

Expert Opinion

Max 5
StrongerWeaker
Randomized Trials
Level 1b
60

60 / 100

Quality score

Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.

Can establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1Yes — these changes are clinically meaningful: more muscle helps mobility and survival, less fat and better blood sugar reduce diabetes risk, higher hemoglobin fights anemia.
  2. 2Muscle up by 1.69kg in arms/legs, 4.74kg total; fat down by 4.34kg; bone mass up by 0.08kg; bone density up 0.287 points; blood count up 10.2g/L; blood sugar (HbA1c) down 0.35%.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

Journal of hepatology

Year

2016

Authors

M. Sinclair, M. Grossmann, R. Hoermann, P. Angus, P. Gow

226 citations
Analysis v3
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.